Cytek Biosciences (CTKB) EBT (2020 - 2026)
Cytek Biosciences (CTKB) posted EBT of -$17.4 million for Q1 2026, down 330.98% on a QoQ basis from -$4.0 million in Q4 2025, and down 54.21% year-over-year from -$37.9 million in Q1 2025.
Cytek Biosciences (CTKB) EBT (2020 - 2026) Analysis & Trends
Cytek Biosciences' EBT history runs 7 years deep, the most recent figure standing at -$17.4 million for Q1 2026.
- Quarterly EBT fell 54.21% year-over-year to -$17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35.9 million (down 350.93% YoY) and the FY2025 annual result came in at -$29.8 million, down 423.53% from the prior year.
- EBT was -$17.4 million for Q1 2026 at Cytek Biosciences, down from -$4.0 million in the prior quarter.
- Across five years, EBT topped out at $10.3 million in Q4 2024 and bottomed at -$17.4 million in Q1 2026.
- A 5-year average of -$4.0 million and a median of -$4.2 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT jumped 826.58% — and 2025, when it plunged 5048.41%.
- Cytek Biosciences' EBT stood at $4.1 million in 2022, then declined by 0.07% to $4.1 million in 2023, then soared by 151.11% to $10.3 million in 2024, then sank by 139.05% to -$4.0 million in 2025, then tumbled by 330.98% to -$17.4 million in 2026.
- Business Quant data shows CTKB's EBT at -$17.4 million in Q1 2026, -$4.0 million in Q4 2025, and -$7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -17.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.37 Mn |
| Dec 31, 2025 | -4.03 Mn |
| Sep 30, 2025 | -7.77 Mn |
| Jun 30, 2025 | -6.78 Mn |
| Mar 31, 2025 | -11.27 Mn |
| Dec 31, 2024 | 10.32 Mn |
| Sep 30, 2024 | 157,000.00 |
| Jun 30, 2024 | -7.19 Mn |
| Mar 31, 2024 | -8.99 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | -4.19 Mn |
| Jun 30, 2023 | -6.60 Mn |
| Mar 31, 2023 | -9.04 Mn |
| Dec 31, 2022 | 4.11 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | -3.30 Mn |
| Dec 31, 2021 | 444,000.00 |
| Sep 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 3.27 Mn |